Evidence map›Paper›PMID 39228565›Full record

ArticleJournal of family medicine and primary care2024

Clinical cohort of nonalcoholic fatty liver disease in a primary care setting.

Julia R Gips, Lisa Yanek, Jiajun Wu, James P Hamilton, Tinsay A Woreta, Jeanne M Clark

Abstract read
In one paragraph

Article in Journal of family medicine and primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia R GipsPGY-3 Osler Medical Residency, Johns Hopkins School of Medicine, Baltimore, USA.
Lisa YanekAssistant Professor of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, USA.
Jiajun WuSenior Business Intelligence Analyst at BEAD Core, Johns Hopkins School of Medicine, Baltimore, USA.
James P HamiltonDirector of Hepatology and Associate Professor of Medicine, Johns Hopkins School of Medicine, Baltimore, USA.
Tinsay A WoretaProgram Director, Gastroenterology and Transplant Hepatology Fellowships, Assistant Professor of Medicine, Johns Hopkins School of Medicine, Baltimore, USA.
Jeanne M ClarkProfessor of Medicine and Epidemiology Director, Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Nonalcoholic fatty liver disease (NAFLD) is increasingly common, and primary care physicians (PCPs) are often the first to diagnose NAFLD. While guidelines on NAFLD management in primary care exist, there are limited data on clinical practice patterns. Approach: We gathered data from over 370,000 patients with at least one PCP visit between July 2016 and September 2023. Using ICD-10 codes to identify patients with a diagnosis of NAFLD or Nonalcoholic Steatohepatitis (NASH), we extracted demographics, comorbidities, laboratory results, prescriptions, imaging orders, and referrals to describe their care. Results: We identified 10,334 patients with a diagnosis code of NAFLD (93.1%) and/or NASH (16.7%) during a PCP visit. Just over half (54.8%) were female, mean age was 52.8 years, and mean BMI was 33.2 kg/m Conclusion: PCPs have not widely implemented clinical practice guidelines for NAFLD, resulting in suboptimal care including for the substantial minority with fibrosis or cirrhosis. Patients might benefit from targeted NAFLD education for PCPs and improved decision and management support.

Indexed as

Metabolic syndromeNAFLDprimary care

Identifiers

PMID39228565
PMCPMC11368356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.